Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 8, 2021

DrugPatentWatch Database Preview

Patent: 9,346,769

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,346,769
Title:Tetrazolones as inhibitors of fatty acid synthase
Abstract: Provided herein are tetrazolone FASN inhibitors of the formula (I): ##STR00001## or a pharmaceutically acceptable form thereof; wherein the variables R.sup.A, R.sup.B and R.sup.C are defined herein. Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections.
Inventor(s): Bahadoor; Adilah (Stittsville, CA), Castro; Alfredo C. (Winchester, MA), Chan; Lawrence K. (Brookline, MA), Keaney; Gregg F. (Lexington, MA), Nevalainen; Marta (Weymouth, MA), Nevalainen; Vesa (Weymouth, MA), Peluso; Stephane (Brookline, MA), Snyder; Daniel A. (Somerville, MA), Tibbitts; Thomas T. (Westford, MA)
Assignee: Infinity Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:13/975,236
Patent Claims:see list of patent claims

Details for Patent 9,346,769

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 1986-06-04 ⤷  Free Forever Trial 2030-05-05
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Free Forever Trial 2030-05-05
Hoffmann-la Roche Inc. ROFERON-A interferon alfa-2a For Injection 103145 1986-06-04 ⤷  Free Forever Trial 2030-05-05
Kadmon Pharmaceuticals Llc INFERGEN interferon alfacon-1 Injection 103663 1997-10-06 ⤷  Free Forever Trial 2030-05-05
Horizon Therapeutics Ireland Dac ACTIMMUNE interferon gamma-1b Injection 103836 1999-02-25 ⤷  Free Forever Trial 2030-05-05
Merck Sharp & Dohme Corp. PEGINTRON peginterferon alfa-2b Injection 103949 2001-01-19 ⤷  Free Forever Trial 2030-05-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.